Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV)- a randomised, non-inferiority, phase 3 trial and its extension study RETOUR MarcGuevreguian2021-03-22T20:49:40+01:00
